Pulmonary intravascular macrophages: Prime suspects as cellular mediators of porcine CARPA

Domokos Csukás, Rudolf Urbanics, G. Wéber, L. Rosivall, J. Szebeni

Research output: Article

11 Citations (Scopus)

Abstract

Pigs provide a highly sensitive and quantitative in vivo model for complement (C) activation-related pseudoallergy (CARPA), a hypersensitivity reaction caused by some state-of-art nanomedicines. In an effort to understand the mechanism of the pigs' unique sensitivity for CARPA, this review focuses on pulmonary intravascular macrophages (PIMs), which are abundantly present in the lung of pigs. These cells represent a macrophage subpopulation whose unique qualities explain the characteristic symptoms of CARPA in this species, most importantly the rapidly (within minutes) developing pulmonary vasoconstriction, leading to elevation of pulmonary arterial pressure. The unique qualities of PIM cells include the following; 1) they are strongly adhered to the capillary walls via desmosome-like intercellular adhesion plaques, which secure stable and lasting direct exposition of the bulk of these cells to the blood stream; 2) their ruffled surface engaged in intense phagocytic activity ensures efficient binding and phagocytosis of nanoparticles; 3) PIM cells express anaphylatoxin receptors, this way C activation can trigger these cells, 4) they also express pattern recognition molecules on their surface, whose engagement with certain coated nanoparticles may also activate these cells or act in synergy with anaphylatoxins and, finally 5) their high metabolic activity and capability for immediate secretion of vasoactive mediators upon stimulation explain the circulatory blockage and other robust physiological effects that their stimulation may cause. These qualities taken together with reports on liposome uptake by PIM cells during CARPA and the possible presence of these cells in human lung suggests that PIM cells may be a potential therapeutic target against CARPA.

Original languageEnglish
Pages (from-to)27-36
Number of pages10
JournalEuropean Journal of Nanomedicine
Volume7
Issue number1
DOIs
Publication statusPublished - jan. 1 2015

Fingerprint

macrophages
Alveolar Macrophages
Swine
Chemical activation
activation
cells
Anaphylatoxins
swine
Lung
Nanoparticles
Medical nanotechnology
stimulation
lungs
Liposomes
Macrophages
vasoconstriction
Nanomedicine
physiological effects
Desmosomes
Pattern recognition

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Physical and Theoretical Chemistry
  • Biomedical Engineering

Cite this

@article{98fd3fc6a4e24fba8d6502a7cae52cd4,
title = "Pulmonary intravascular macrophages: Prime suspects as cellular mediators of porcine CARPA",
abstract = "Pigs provide a highly sensitive and quantitative in vivo model for complement (C) activation-related pseudoallergy (CARPA), a hypersensitivity reaction caused by some state-of-art nanomedicines. In an effort to understand the mechanism of the pigs' unique sensitivity for CARPA, this review focuses on pulmonary intravascular macrophages (PIMs), which are abundantly present in the lung of pigs. These cells represent a macrophage subpopulation whose unique qualities explain the characteristic symptoms of CARPA in this species, most importantly the rapidly (within minutes) developing pulmonary vasoconstriction, leading to elevation of pulmonary arterial pressure. The unique qualities of PIM cells include the following; 1) they are strongly adhered to the capillary walls via desmosome-like intercellular adhesion plaques, which secure stable and lasting direct exposition of the bulk of these cells to the blood stream; 2) their ruffled surface engaged in intense phagocytic activity ensures efficient binding and phagocytosis of nanoparticles; 3) PIM cells express anaphylatoxin receptors, this way C activation can trigger these cells, 4) they also express pattern recognition molecules on their surface, whose engagement with certain coated nanoparticles may also activate these cells or act in synergy with anaphylatoxins and, finally 5) their high metabolic activity and capability for immediate secretion of vasoactive mediators upon stimulation explain the circulatory blockage and other robust physiological effects that their stimulation may cause. These qualities taken together with reports on liposome uptake by PIM cells during CARPA and the possible presence of these cells in human lung suggests that PIM cells may be a potential therapeutic target against CARPA.",
keywords = "adverse immune effects, anaphylatoxins, anaphylaxis, complement, hypersensitivity reactions, nanomedicines, pulmonary intravascular macrophages",
author = "Domokos Csuk{\'a}s and Rudolf Urbanics and G. W{\'e}ber and L. Rosivall and J. Szebeni",
year = "2015",
month = "1",
day = "1",
doi = "10.1515/ejnm-2015-0008",
language = "English",
volume = "7",
pages = "27--36",
journal = "European Journal of Nanomedicine",
issn = "1662-5986",
publisher = "Walter de Gruyter GmbH",
number = "1",

}

TY - JOUR

T1 - Pulmonary intravascular macrophages

T2 - Prime suspects as cellular mediators of porcine CARPA

AU - Csukás, Domokos

AU - Urbanics, Rudolf

AU - Wéber, G.

AU - Rosivall, L.

AU - Szebeni, J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pigs provide a highly sensitive and quantitative in vivo model for complement (C) activation-related pseudoallergy (CARPA), a hypersensitivity reaction caused by some state-of-art nanomedicines. In an effort to understand the mechanism of the pigs' unique sensitivity for CARPA, this review focuses on pulmonary intravascular macrophages (PIMs), which are abundantly present in the lung of pigs. These cells represent a macrophage subpopulation whose unique qualities explain the characteristic symptoms of CARPA in this species, most importantly the rapidly (within minutes) developing pulmonary vasoconstriction, leading to elevation of pulmonary arterial pressure. The unique qualities of PIM cells include the following; 1) they are strongly adhered to the capillary walls via desmosome-like intercellular adhesion plaques, which secure stable and lasting direct exposition of the bulk of these cells to the blood stream; 2) their ruffled surface engaged in intense phagocytic activity ensures efficient binding and phagocytosis of nanoparticles; 3) PIM cells express anaphylatoxin receptors, this way C activation can trigger these cells, 4) they also express pattern recognition molecules on their surface, whose engagement with certain coated nanoparticles may also activate these cells or act in synergy with anaphylatoxins and, finally 5) their high metabolic activity and capability for immediate secretion of vasoactive mediators upon stimulation explain the circulatory blockage and other robust physiological effects that their stimulation may cause. These qualities taken together with reports on liposome uptake by PIM cells during CARPA and the possible presence of these cells in human lung suggests that PIM cells may be a potential therapeutic target against CARPA.

AB - Pigs provide a highly sensitive and quantitative in vivo model for complement (C) activation-related pseudoallergy (CARPA), a hypersensitivity reaction caused by some state-of-art nanomedicines. In an effort to understand the mechanism of the pigs' unique sensitivity for CARPA, this review focuses on pulmonary intravascular macrophages (PIMs), which are abundantly present in the lung of pigs. These cells represent a macrophage subpopulation whose unique qualities explain the characteristic symptoms of CARPA in this species, most importantly the rapidly (within minutes) developing pulmonary vasoconstriction, leading to elevation of pulmonary arterial pressure. The unique qualities of PIM cells include the following; 1) they are strongly adhered to the capillary walls via desmosome-like intercellular adhesion plaques, which secure stable and lasting direct exposition of the bulk of these cells to the blood stream; 2) their ruffled surface engaged in intense phagocytic activity ensures efficient binding and phagocytosis of nanoparticles; 3) PIM cells express anaphylatoxin receptors, this way C activation can trigger these cells, 4) they also express pattern recognition molecules on their surface, whose engagement with certain coated nanoparticles may also activate these cells or act in synergy with anaphylatoxins and, finally 5) their high metabolic activity and capability for immediate secretion of vasoactive mediators upon stimulation explain the circulatory blockage and other robust physiological effects that their stimulation may cause. These qualities taken together with reports on liposome uptake by PIM cells during CARPA and the possible presence of these cells in human lung suggests that PIM cells may be a potential therapeutic target against CARPA.

KW - adverse immune effects

KW - anaphylatoxins

KW - anaphylaxis

KW - complement

KW - hypersensitivity reactions

KW - nanomedicines

KW - pulmonary intravascular macrophages

UR - http://www.scopus.com/inward/record.url?scp=84924907634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924907634&partnerID=8YFLogxK

U2 - 10.1515/ejnm-2015-0008

DO - 10.1515/ejnm-2015-0008

M3 - Article

AN - SCOPUS:84924907634

VL - 7

SP - 27

EP - 36

JO - European Journal of Nanomedicine

JF - European Journal of Nanomedicine

SN - 1662-5986

IS - 1

ER -